Polycystic ovary syndrome, gonadal dysfunction, etc.
Conditions
Interventions
Gold Standard:Beckman Coulter, Inc. (USA) produced the Inhibin A assay kit (chemiluminescence method) Access INHIBIN A, used as a comparative reagent.
Index test:Inhibin A Assay Kit (Magnetic Microparticle Chemiluminescence) developed by Shenzhen New Industries Biomedical Engineering Co., Ltd.
Sponsors
Sichuan Provincial People's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients with suspected reproductive hormone disorders: (1) Women have clinical manifestations such as hirsutism, infertility, amenorrhea, menopause, and irregular menstruation;(2) Clinical manifestations such as infertility and early development of secondary sexual characteristics in men. You must meet any of the requirements of (1) and (2) to be selected. 2.Patients with reproductive hormone disorders: (1) Women with polycystic ovary syndrome, premature ovarian failure and decreased ovarian reserve;(2) Men with testicular dysfunction and other phenomena;(3) Those with abnormal laboratory reproductive hormone examination. Applicants must meet the requirements of (1) (3) or (2) (3) to be selected. 3. Confusing cases: abnormal thyroid function, etc. 4.Samples containing interfering substances such as lipidemia, hemolysis, jaundice, etc., or samples containing cross-substance such as luteinizing hormone and thyroid-stimulating hormone.
Exclusion criteria
Exclusion criteria: 1.The clinical information of the subject's sample is incomplete and cannot be traced. 2. The subject's sample does not meet the requirements for sample collection and preservation. 3. The subject's sample is suspected to be turbid due to microbial contamination. 4. Duplicate enrollment of the subject's sample. 5. The sample size of the subject is not enough to meet the testing requirements of the assessment reagent and the comparison reagent. 6. Other reasons that the investigator considers unsuitable for enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Compare the results of reagent tests;Evaluate the test results of reagents; | — |
Countries
China
Contacts
Public ContactHuang Yi
Sichuan Provincial People's Hospital
Outcome results
None listed